NIH-funded research NIH-funded research

Selective autophagy and aging in Alzheimer’s disease: a small-molecule approach

Official title: Role of selective autophagy in aging and neurodegeneration: a small molecule approach

Funded at University of Arizona · NIH-11470689 · Data updated 2026-11-12

A patient-facing grant exploring how boosting the cell’s recycling system might protect brain cells in Alzheimer-related illness through a targeted drug approach.

More Aging research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startFebruary 15, 2023
Project endFebruary 28, 2029
Funding year2026
Award (this year)$249,096
NIH project number4R00AG080109-03
Project IDNIH-11470689 on NIH RePORTER

Who could benefit from this research

Could help

Adults with Alzheimer’s disease or related dementias and those at risk of progression may eventually benefit from therapies targeting selective autophagy.

Less likely to help

Individuals without Alzheimer’s-related conditions or those not suited to participate in early-phase pharmacology studies may not benefit.

What this research studies

This project looks at how aging affects brain cells and whether small molecules can enhance selective autophagy to clear toxic materials that build up in Alzheimer’s disease. The research will focus on how lipid droplets and damaged proteins are degraded in brain cells and how this process could prevent neurodegeneration. By testing targeted compounds, the team hopes to find strategies that support brain cell health in people with Alzheimer’s disease or related dementias.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that help protect brain cells in Alzheimer’s disease by improving cellular cleanup processes.

How similar studies have gone: Other studies suggest that enhancing autophagy can influence neurodegenerative processes, but selective lipophagy as a therapeutic target remains under investigation.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Tan, Ee Phie — University of Arizona
  • Study coordinator: Tan, Ee Phie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.